<?xml version="1.0" encoding="UTF-8" standalone="no" ?>
<rss version="2.0">
  <channel>
    <title>Kouwenhoven, A.E.</title>
    <link>http://repub.eur.nl/res/aut/23801/</link>
    <description>List of Publications</description>
    <language>en</language>
    <image>
      <url>http://repub.eur.nl/static-eur/img/logo.png</url>
      <title>RePub, Erasmus University Rotterdam</title>
      <link>http://repub.eur.nl</link>
    </image>
    <item>
      <title>Chronic transplant dysfunction: Etiological and pathophysiological aspects (Doctoral Thesis)</title>
      <link>http://repub.eur.nl/res/pub/19998/</link>
      <pubDate>1999-06-30T00:00:00Z</pubDate>
      <description>Organ transplantation has saved the life of many people throughout the world, who
suffered from end·stage organ failure. The University Hospital Rotterdam·Dijkzigt,
is one of the Dutch organ transplant centers, in which kidney, heart and liver
transplantation are performed. In close conjunction with hurdles encountered in
clinical organ transplantation, experimental transplantation research has been for
a long time one ofthe points ofinterestofthe Department of Surgery. Experimental
work in small and large animal models to overcome the thresholds to successful
intestinal transplantation has been of special interest for years. My scientific
curiosity for the transplantation·field was provoked during participation as a
student in a research project at the Laboratory for Experimental Surgery to
investigate xenogeneic islet transplantation as therapy for diabetes mellitus.
In addition to search for new transplant modalities, we also try to improve
long. term graft survival as data show that clinical organ transplantation has not
yet achieved its full potential on the long· term. Beyond one year post·
transplantation, the half·life of organ grafts has little changed since the
beginning ofthe transplantation.era. Long·term graft survival is predominantly
hampered by chronic transplant dysfunction (CTD). So far, no drugs can
prevent CTD and a therapeutic strategy is not within hand's reach, since causes
and mechanisms leading to CTD are poorly known. Retransplantation is at
present the only effective therapy.
In '995, I first started experiments at the Laboratory for Experimental Surgery
to gain insight into the etiology of CTD: The role of ischemia and surgery was
shldied in an aorta transplantation modeL Participating in ongoing experiments,
at the Departments of Medicine and Surgery, Monash University, Melbourne,
Australia I investigated the pathogenesis of CTD after small bowel transplantation
in a rat modeL From a clinical point of view, I continued experiments on the
pathogenesis in the kidney and studied the effect of ischemia, surgery and
genetics. TI,ese studies were carried out in close collaboration with the
Departments of Paediatric Surgery and Pathology, Erasmus University and with
the Department of Nephrology, University Hospital, Essen, Germany.
This thesis outlines the problem of CTD, presents the results of the
experimental studies mentioned above, and finally discusses tl,e results.</description>
    </item>
  </channel>
</rss>